Clinical trials

Latest

Karen and Evie’s 23 day Squatty Botty

We are taking on the Squatty Botty challenge to raise much needed funds for dear little Ollie
Leeanne Brennan
A Half Marathon for Henry The Brave

Henry has high-risk neuroblastoma, an aggressive childhood cancer that has a 40-50% chance of long-term survival at diagnosis. His family need support for his on going treatment.
Naomi Bentham

Lily-Mae, Ireland’s Tiny Dancer, supports Solving Kids’ Cancer

Lily-Mae from Galway, Ireland will be celebrating her 12th birthday this April, but for her parents Judith and Leighton every day is a blessing.
Corey is thriving after neuroblastoma battle

Family donate almost £150,000 to neuroblastoma research
Solving Kids' Cancer welcomes Alexandra Lane to the Board of Trustees

Alexandra Lane was formally voted on and welcomed to our Board of Trustees this week. We are thrilled to welcome Alex to the team.
BEACON study opens in Europe

The much-anticipated BEACON study amendment is now open and recruiting patients.
Steve Richards to step down as Chief Executive

CEO to leave Solving Kids' Cancer after three years in the role.
Solving Kids’ Cancer appoints new Chief Executive Officer

Solving Kids’ Cancer, a national neuroblastoma charity, has appointed Gail Jackson as its new Chief Executive Officer.
Charities fund new clinical trial

Solving Kids’ Cancer, with Neuroblastoma UK, has awarded a grant of £609,762.40 to enable the SIOPEN High-Risk Neuroblastoma Clinical Trial 2 (HR-NBL2) to open in the UK, it is anticipated to open in early 2021.
First Three Months

Gail Jackson, CEO, launches her blog. Reflecting on personal resilience, our work and joining Solving Kids' Cancer as COVID hit.
Ewen's Journey

Ewen sadly passed away on 28th September 2020.
Celebrating Success and Acknowledging Challenge

Our CEO, Gail, reflects on 'Pandemic Fatigue' and the importance of celebrating success in the face of challenge.